Possible mechanisms relating diet and risk of colon cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 12, 2000, Pages 1271-1279

  Bruce, W Robert ^a,b   Giacca, Adria ^b   Medline, Alan ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYCLOOXYGENASE 2; EMOLLIENT AGENT; FATTY ACID; INSULIN; REACTIVE OXYGEN METABOLITE;

CANCER RISK; CELL PROLIFERATION; COLON CANCER; DIETARY INTAKE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; LONG TERM EXPOSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

CARCINOGENS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DIET; ENERGY INTAKE; ENZYME INDUCTION; HUMANS; INSULIN RESISTANCE; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REACTIVE OXYGEN SPECIES; RISK;

EID: 0034524443     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Colon cancer: Review of the epidemiology
2. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: Evidence from the combined analysis of 13 case-control studies
3. The relationship between dietary fat intake and colorectal cancer: Evidence from combined analysis of 13 case-control studies
4. Recent hypotheses for the origin of colon cancer
5. The causes and prevention of cancer
6. Colorectal cancer: Molecules and populations
7. Occurrence, identification, and bacterial mutagenicity of heterocyclic amines in cooked food
8. Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas
9. Fat and calories in colon and breast cancer: From animal studies to controlled clinical trials
10. Effect of exercise on intestinal tumor development in the male Fischer rat after exposure to azoxymethane
11. Calories, fat and cancer
12. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk?
13. Insulin and colon cancer
14. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
15. Serum lipids and adenomas of the left colon and rectum
16. Insulin resistance and the risk of colorectal neoplasia
17. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
18. Serum C-peptide, IGF-I, IGF-binding proteins and risk of colorectal cancer in women
19. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan)
20. Increased blood glucose and insulin, body size, and incident colorectal cancer
21. Colorectal cancer: Another complication of diabetes mellitus?
22. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ
23. Energy density, palatability, and satiety: Implications for weight control
24. Regulation of food intake
25. Dietary fiber and energy regulation
26. Weight loss on a low-fat diet: Consequence of the imprecision of the control of food intake in humans
27. Effects of free fatty acids and ketone bodies on in vivo non-insulin-mediated glucose utilization and production in humans
28. Mechanisms of fatty acid-induced inhibition of glucose uptake
29. Mechanisms linking diet and colorectal cancer: The possible role of insulin resistance
30. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
31. Insulin injections promote the growth of aberrant crypt foci in the colon of rats
32. Insulin promotion of colon tumors in rats
33. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high fat diet
34. Insulin resistance and colon cancer promotion: Effects of a high fat diet on insulin resistance, aberrant crypt foci (ACF) promotion, plasma energy substrates and intracellular triglycerides in rats
35. Aberrant crypt focus promotion and glucose intolerance: Correlation in the rat across diets differing in fat, n-3 fatty acids and energy
36. Toxicity of orally administered fat to the colonic epithelium of mice
37. Sucrose enhancement of the early steps of colon carcinogenesis in mice
38. Effect of lipoproteins on cultured human mesangial cells
39. Mitogenic properties of insulin and insulin analogues mediated by insulin receptor
40. Insulin decreases circulating vitamin E levels in humans
41. Oxidative stress and insulin action: Is there a relationship?
42. Lipid peroxidation and antioxidant status in experimental diabetes
43. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
44. Are the β cell signalling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?
45. Disorders in cell circuitry associated with multistage carcinogenesis: Exploitable targets for cancer prevention and therapy
46. Diet, aberrant crypt foci and colorectal cancer
47. Identification of dysplasia in human colonic aberrant crypt foci
48. Effects of dietary constituents on carcinogenesis in different tumor models
49. Inhibition of aberrant crypt foci by chemopreventive agents
50. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats
51. Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP)-induced DNA adducts and colonic aberrant crypts in the F344 rat
52. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats
53. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
54. Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis
55. A fish oil-derived concentrate enriched in eicosopentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant cryp foci in rat colon
56. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice
57. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development
58. Minmouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression
59. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogeninduced aberrant crypt foci in rats
60. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase
61. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by naturally occurring flavonoids, diosmin and hesperidin
62. Influence of ethyl-3-(4′-geranyloxy-3′-methoxyphenyl)-2-propenoate (EGMP) on early stage colon carcinogenesis in rats treated with azoxymethane
63. The mechanism of facilitated cell membrane resealing
64. Gastrointestinal cell plasma membrane wounding and resealing in vivo
65. Dextran sulfate enhances the level of an oxidative damage biomarker, 8-oxo- 7,8dihydro-2′-deoxyguanosine, in rat colonic mucosa
66. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa
67. Comparative electron-microscopic features of normal, hyperplastic, and adenomatous human colonic epithelium. II. Variations in surface architecture found by scanning electron microscopy
68. Increased tight junctional permeability is associated with the development of colon cancer
69. Absorption and secretion of electrolytes and water by the human colon, with particular reference to benign adenoma and papilloma
70. Validation of polyethylene glycol 3350 as a poorly absorbable marker for intestinal perfusion studies
71. Effect of pluronic F68 on growth of fibroblasts in suspension on rotary shaker
72. Short-chain fructooligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans
73. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits attachment and cell invasion by enterovirulent bacteria
74. The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro
75. Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins
76. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells
77. The contribution of sulfate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis
78. Prostaglandin J2 and 15-deoxy-δ 12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells
79. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis
80. Effects of peroxidative stress and age on the concentration of a deoxyguanosine-malondialdehyde adduct in rat DNA
81. Reactive oxygen species and antioxidants in signal transduction and gene expression
82. Cancer risk and oxidative DNA damage in man
83. Time course of mammalian cell electropermeabilization observed by millisecond imaging of membrane property changes during the pulse
84. The generation of reactive oxygen species associated with long-lasting pulse-induced electropermeabilization of mammalian cells is based on a non-destructive alteration of the plasma membrane
85. Intercellular communication in normal and aberrant crypts of rat colon mucosa
86. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
87. Fecal calprotectin concentration in patients with colorectal carcinoma
88. Faecal calprotectin levels in a high risk population for colorectal neoplasia
89. Improved assay for fecal calprotectin
90. Granulocyte marker protein is increased in stools from rats with azoxymethane - Induced colon cancer
91. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice
92. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma
93. Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis
94. Recent advances in light-induced fluorescence endoscopy (LIFE) of the gastrointestinal tract
95. Light-induced fluorescence endoscopy of the gastrointestinal tract
96. Structural characterization and immunochemical detection of a flurophore derived from 4-hydroxy-2-nonenal and lysine
97. Cell kinetic evaluation of human colonic aberrant crypts
98. Evidence for genetic instability in human colonic aberrant crypt foci
99. Microsatellite instability in aberrant crypt foci from human colons
100. Stem cells: The intestinal stem cell as a paradigm
101. Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state
102. Dietary polyunsaturated fatty acids and inflammatory mediator production
103. Methyl donors in the diet and responses to chemical carcinogens
104. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets
105. Dietary cholesterol inhibits the development of aberrant crypt foci in the colon
106. Lipid absorption and intestinal tumor incidence in rats fed on varying levels of calcium and butterfat
107. Soumes, chemistry, and processing of oils and fats
108. Dietary fiber, fermentation and large bowel cancer
109. On the presence of inulin and oligofructose as natural ingredients in the western diet
110. Effect of meat and resistant starch on fecal excretion of apparent N-nitroso compounds and ammonia from the human large bowel
111. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance
112. Evaluation of the potential for Olestra to affect the availability of dietary phytochemicals
113. Interaction of dietary antioxidants in vivo: How fruit and vegetables prevent disease?
114. N-acetylcysteine suppression of the proliferation index in the colon of patients with previous adenomatous colonic polyps
115. A clinical trial of antioxidant vitamins to prevent colorectal adenoma
116. Lack of effect of high-fiber cereal supplement on the recurrence of colorectal adenomas
117. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas
118. Morphological and morphometric measurements in colorectal mucosa of subjects at increased risk for colonic neoplasia